Central Florida Pulmonary Group — Orlando, Florida

Central Florida Pulmonary Group is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Central Florida Pulmonary Group has participated in 31 clinical trials with 6 currently active.

Therapeutic areas: Pulmonary Arterial Hypertension, Systemic Sclerosis With and Without Interstitial Lung Disease, PAH.

Sponsors: Actelion, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, United Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Orlando

Browse all research sites in Florida · View every site in Orlando

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Florida Pulmonary Group?

Central Florida Pulmonary Group has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Florida Pulmonary Group conducted?

Central Florida Pulmonary Group has 31 clinical trials on record, with 6 currently active. Their work covers Pulmonary Arterial Hypertension, Systemic Sclerosis With and Without Interstitial Lung Disease, PAH.

Is Central Florida Pulmonary Group accredited by Crixeo Clinical Trials?

Central Florida Pulmonary Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Florida Pulmonary Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.